Skip to main content
. 2018 Dec 17;80(5):540–546. doi: 10.1055/s-0038-1676628

Fig. 3.

Fig. 3

Kaplan–Meier plot demonstrates freedom from linear progression for tumors while off bevacizumab (dashed line) and during bevacizumab treatment (solid line). Cox regression demonstrated a significant reduction in linear progression with bevacizumab treatment.